Find a Tender · Contract

Immunoglobulin Products - Hyperimmune [4363271]

A public procurement published by Procurement and Logistics Service via Find a Tender.

Find a TenderContract
Award value
£2.2m
Tender value
1
Suppliers
1
Awards
2
Notices
Contract
Stage

Overview

Immunoglobulin Products - Hyperimmune [4363271]

Key details

Source
Find a Tender
Lifecycle stage
Contract
Status
active
CPV classification
38000000 — Laboratory, optical and precision equipments (excl. glasses)
Currency
GBP
Total award value
Tender value
£2,212,992
First published
3 Aug 2023
Last updated
13 Dec 2023
View the original notice

Awards

1 award recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
BIO PRODUCTS LABORATORY LIMITED07343036active

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeImmunoglobulin Products - Hyperimmune [4363271]
  2. Award,contractImmunoglobulin Products - Hyperimmune [4363271]

All suppliers

Frameworks & programmes

More from Procurement and Logistics Service

FAQs about this procurement

Who is the buyer for "Immunoglobulin Products - Hyperimmune [4363271]"?

Immunoglobulin Products - Hyperimmune [4363271] is a UK public-sector procurement published by Procurement and Logistics Service via Find a Tender.

Has "Immunoglobulin Products - Hyperimmune [4363271]" been awarded?

Yes — 1 award is recorded, with a reported total value of £2,212,992. The current lifecycle stage is "Contract".

Which suppliers are involved in "Immunoglobulin Products - Hyperimmune [4363271]"?

1 supplier is linked: BIO PRODUCTS LABORATORY LIMITED.

What is "Immunoglobulin Products - Hyperimmune [4363271]" worth?

The reported tender value is £2,212,992.

When was "Immunoglobulin Products - Hyperimmune [4363271]" published?

It was first published on 3 Aug 2023 and last updated on 13 Dec 2023, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable